Kawaoka Y - Search Results

1

Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection.

Davis CW, Jackson KJL, McElroy AK, Halfmann P, Huang J, Chennareddy C, Piper AE, Leung Y, Albariño CG, Crozier I, Ellebedy AH, Sidney J, Sette A, Yu T, Nielsen SCA, Goff AJ, Spiropoulou CF, Saphire EO, Cavet G, Kawaoka Y, Mehta AK, Glass PJ, Boyd SD, Ahmed R. Davis CW, et al. Among authors: kawaoka y. Cell. 2019 May 30;177(6):1566-1582.e17. doi: 10.1016/j.cell.2019.04.036. Epub 2019 May 16. Cell. 2019. PMID: 31104840 Free PMC article.

2

Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture.

Neumann G, Feldmann H, Watanabe S, Lukashevich I, Kawaoka Y. Neumann G, et al. Among authors: kawaoka y. J Virol. 2002 Jan;76(1):406-10. doi: 10.1128/jvi.76.1.406-410.2002. J Virol. 2002. PMID: 11739705 Free PMC article.

3

Human influenza a viral genes responsible for the restriction of its replication in duck intestine.

Hatta M, Halfmann P, Wells K, Kawaoka Y. Hatta M, et al. Among authors: kawaoka y. Virology. 2002 Apr 10;295(2):250-5. doi: 10.1006/viro.2002.1358. Virology. 2002. PMID: 12033783 Free article.

4

Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses.

Takada A, Feldmann H, Stroeher U, Bray M, Watanabe S, Ito H, McGregor M, Kawaoka Y. Takada A, et al. Among authors: kawaoka y. J Virol. 2003 Jan;77(2):1069-74. doi: 10.1128/jvi.77.2.1069-1074.2003. J Virol. 2003. PMID: 12502822 Free PMC article.

5

Antibody-dependent enhancement of Ebola virus infection.

Takada A, Feldmann H, Ksiazek TG, Kawaoka Y. Takada A, et al. Among authors: kawaoka y. J Virol. 2003 Jul;77(13):7539-44. doi: 10.1128/jvi.77.13.7539-7544.2003. J Virol. 2003. PMID: 12805454 Free PMC article.

6

Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics.

Watanabe S, Watanabe T, Noda T, Takada A, Feldmann H, Jasenosky LD, Kawaoka Y. Watanabe S, et al. Among authors: kawaoka y. J Virol. 2004 Jan;78(2):999-1005. doi: 10.1128/jvi.78.2.999-1005.2004. J Virol. 2004. PMID: 14694131 Free PMC article.

7

Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.

Kobasa D, Takada A, Shinya K, Hatta M, Halfmann P, Theriault S, Suzuki H, Nishimura H, Mitamura K, Sugaya N, Usui T, Murata T, Maeda Y, Watanabe S, Suresh M, Suzuki T, Suzuki Y, Feldmann H, Kawaoka Y. Kobasa D, et al. Among authors: kawaoka y. Nature. 2004 Oct 7;431(7009):703-7. doi: 10.1038/nature02951. Nature. 2004. PMID: 15470432

8

Characterization of a human H5N1 influenza A virus isolated in 2003.

Shinya K, Hatta M, Yamada S, Takada A, Watanabe S, Halfmann P, Horimoto T, Neumann G, Kim JH, Lim W, Guan Y, Peiris M, Kiso M, Suzuki T, Suzuki Y, Kawaoka Y. Shinya K, et al. Among authors: kawaoka y. J Virol. 2005 Aug;79(15):9926-32. doi: 10.1128/JVI.79.15.9926-9932.2005. J Virol. 2005. PMID: 16014953 Free PMC article.

9

Molecular determinants of Ebola virus virulence in mice.

Ebihara H, Takada A, Kobasa D, Jones S, Neumann G, Theriault S, Bray M, Feldmann H, Kawaoka Y. Ebihara H, et al. Among authors: kawaoka y. PLoS Pathog. 2006 Jul;2(7):e73. doi: 10.1371/journal.ppat.0020073. PLoS Pathog. 2006. PMID: 16848640 Free PMC article.

10

Regions in Ebola virus VP24 that are important for nucleocapsid formation.

Noda T, Halfmann P, Sagara H, Kawaoka Y. Noda T, et al. Among authors: kawaoka y. J Infect Dis. 2007 Nov 15;196 Suppl 2:S247-50. doi: 10.1086/520596. J Infect Dis. 2007. PMID: 17940956

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

951 results

Search Page